Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Yvette van Kooyk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5997-3665; OpenAlex author ID A5009217310. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 2 papers

Papers 7

  1. Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions. Last author DOI 10.1038/s42003-024-06087-8↗
  2. In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. Co-author DOI 10.1111/cas.16147↗
  3. Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Co-author DOI 10.1007/s00262-023-03573-6↗
  4. The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer. Co-author DOI 10.1007/s00432-023-05219-7↗
  5. Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer. Last author DOI 10.1136/jitc-2023-007805↗
  6. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Last author DOI 10.1038/s42003-021-02934-0↗
  7. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Last author DOI 10.1038/s41467-021-21550-4↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ernesto Rodríguez · 6 shared papers, 2021–2024 · strength 0.88
  2. Geert Kazemier M · 5 shared papers, 2021–2024 · strength 0.74
  3. Laura L. Meijer · 4 shared papers, 2022–2024 · strength 0.63
  4. Elisa Giovannetti · 4 shared papers, 2021–2024 · strength 0.57
  5. Kelly Boelaars · 4 shared papers, 2021–2024 · strength 0.53
  6. Eline S. Zwart · 3 shared papers, 2023–2024 · strength 0.52
  7. Manfred Wuhrer · 3 shared papers, 2022–2024 · strength 0.42
  8. Lenka N.C. Boyd · 2 shared papers, 2023–2024 · strength 0.35
  9. Tessa Y. S. Le Large · 2 shared papers, 2022–2024 · strength 0.30
  10. Maarten F. Bijlsma · 2 shared papers, 2022–2024 · strength 0.27
  11. Deesje Doppenberg · 1 shared paper, 2023 · strength 0.17
  12. Johanna W. Wilmink · 1 shared paper, 2023 · strength 0.17
  13. Eva Versteijne · 1 shared paper, 2023 · strength 0.17
  14. Marc G. Besselink · 1 shared paper, 2023 · strength 0.17
  15. Chang Liu · 1 shared paper, 2024 · strength 0.16
  16. David Arthur Tuveson · 1 shared paper, 2024 · strength 0.16
  17. Else Driehuis · 1 shared paper, 2022 · strength 0.12
  18. Joanne Verheij · 1 shared paper, 2022 · strength 0.12
  19. Frederike Dijk · 1 shared paper, 2022 · strength 0.12
  20. Hans C. Clevers · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.